<code id='1919795C29'></code><style id='1919795C29'></style>
    • <acronym id='1919795C29'></acronym>
      <center id='1919795C29'><center id='1919795C29'><tfoot id='1919795C29'></tfoot></center><abbr id='1919795C29'><dir id='1919795C29'><tfoot id='1919795C29'></tfoot><noframes id='1919795C29'>

    • <optgroup id='1919795C29'><strike id='1919795C29'><sup id='1919795C29'></sup></strike><code id='1919795C29'></code></optgroup>
        1. <b id='1919795C29'><label id='1919795C29'><select id='1919795C29'><dt id='1919795C29'><span id='1919795C29'></span></dt></select></label></b><u id='1919795C29'></u>
          <i id='1919795C29'><strike id='1919795C29'><tt id='1919795C29'><pre id='1919795C29'></pre></tt></strike></i>

          knowledge

          knowledge

          author:Wikipedia    Page View:243
          Darron Cummings/AP

          Eli Lilly said Friday that it will acquire Dermira, a small biotech developing drugs for chronic skin conditions, for $1.1 billion.

          The centerpiece of the deal is the Dermira drug called lebrikizumab that aims to treat people suffering from moderate-to-severe atopic dermatitis, the most common form of eczema, a disease characterized by inflamed, itchy, and scaly skin.

          advertisement

          Phase 3 clinical trials of lebrikizumab in atopic dermatitis are underway. If successful, the drug could compete against Dupixent, which has grown into a commercial blockbuster for Regeneron Pharmaceuticals and Sanofi.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
          Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

          6:16PresidentJoeBidenspeaksintheRooseveltRoomoftheWhiteHouse,June30,2023.EvanVucci/APPresidentJoeBid

          read more
          First U.S. drug developed to treat liver disease MASH is approved
          First U.S. drug developed to treat liver disease MASH is approved

          AdobeTheFoodandDrugAdministrationonThursdayapprovedthefirstmedicinedevelopedspecificallytotreatthese

          read more
          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more

          Amylyx ALS drug fails trial: Relyvrio patients react with fear, worry

          GwenPetersen,38,anALSpatient,believesthattherecentfailureofAmylyx'sdrugRelyvriocouldstillteachresear